Study Overview
This research focused on how black tea drinks with inulin and dextrin (BTID) affect blood sugar levels in patients with type 2 diabetes (T2DM). It was a well-structured clinical trial comparing BTID to a placebo.
Key Findings
Significant Blood Sugar Control
A total of 35 patients participated, with 32 completing the study. The results showed:
- BTID significantly lowered blood sugar changes at 30 minutes, 1, 2, and 3 hours after meals compared to the placebo.
- 53.1% of patients using BTID had minor blood sugar fluctuations (<2.8 mmol/L), compared to only 28.1% with the placebo.
- The risk of large blood sugar fluctuations was reduced by 65.5% with BTID.
Insulin Response
Patients who consumed BTID also had lower insulin secretion after meals, which suggests improved insulin sensitivity and less burden on pancreatic cells.
Practical Solutions and Value
These results indicate that incorporating BTID can help manage blood sugar levels more effectively for people with T2DM.
Supporting Clinical Practice
Clinical trials are essential for creating safe and effective treatments. Our AI-driven platform, DocSym, makes it easier for healthcare professionals to access crucial information, integrating clinical standards and research into one simple tool.
Enhancing Patient Care
In a fast-paced healthcare setting, our mobile apps streamline scheduling, treatment monitoring, and telemedicine, improving patient management.
Transforming Clinic Operations
By leveraging AI, clinics can enhance workflows, improve patient outcomes, and reduce reliance on paper systems. Learn more about how we can assist at aidevmd.com.
